Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-13004574Phase 4Recruiting
Phase 4, open-label trial of estradiol in menopause and perimenopause (4 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: follicle-stimulating hormone, estradiol and 9 more. Started Apr 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-13004574.